Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
DNA and Cell Biology|February 8, 2006
High levels of oxidative stress globally inhibit gene transcription and histone acetylationMaryse Berthiaume, Nadia Boufaied, Annie Moisan, et al.Anti-Cancer Drugs|March 12, 2010
TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activationNadia Boufaied, My-Anh Wioland, Pierre Falardeau, et al.Scientific Reports|November 15, 2019
Characterization of Matricellular Protein Expression Signatures in Mechanistically Diverse Mouse Models of Kidney InjuryDaniel Feng, Cindy Ngov, Nathalie Henley, et al.The Journal of Pathology|June 18, 2019
Development of a predictive model for stromal content in prostate cancer samples to improve signature performanceNadia Boufaied, Mandeep Takhar, Claire Nash, et al.Molecular and Cellular Endocrinology|May 10, 2017
Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblastsClaire Nash, Nadia Boufaied, Ian G Mills, et al.Disease Models & Mechanisms|July 28, 2019
Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate developmentClaire Nash, Nadia Boufaied, Dunarel Badescu, et al.Journal of Molecular Signaling|November 4, 2010
TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signalingPaul M Campbell, Nadia Boufaied, James J Fiordalisi, et al.Scientific Reports|November 29, 2017
Identification of genes expressed in a mesenchymal subset regulating prostate organogenesis using tissue and single cell transcriptomicsNadia Boufaied, Claire Nash, Annie Rochette, et al.Cancers|February 11, 2023
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 ActivationMd Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh, et al.British Journal of Cancer|February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progressionAnnie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.Pageof 2